The world of public health and vaccine development is set to converge in Washington, DC, as the Global Vaccine Congress 2025 opens its registration. Scheduled from April 21 to 24, 2025, at the Walter E. Washington Convention Center, this prestigious event will unite thousands of experts, policymakers, and industry leaders to explore cutting-edge advancements in vaccines and global health strategies. This gathering serves as a pivotal moment for fostering collaboration and driving innovation in the fight against pandemics and emerging diseases.

A highlight of the congress includes an extensive lineup of sessions featuring prominent figures from leading organizations such as WHO, CEPI, PAHO, and government agencies. Attendees will have the opportunity to engage with over 550 distinguished speakers and network with more than 4,000 participants from across the vaccine ecosystem. The event also showcases breakthrough technologies through exhibitions by over 300 companies. Key sessions will delve into critical topics such as the global response to mPox, the status of innovative cancer vaccines, and the integration of artificial intelligence in vaccine research and manufacturing.

This congress represents a unique chance to shape the future of global health initiatives. By bringing together diverse stakeholders, it fosters dialogue and collaboration that are essential for addressing current and future health challenges. Participants can expect to gain valuable insights into the latest developments in vaccine science, policy-making, and technology. Ultimately, the congress underscores the importance of collective action and innovation in ensuring healthier communities worldwide.